Retail sales up 0.3% in February amid higher prices
NEW YORK – After beginning the year in a buying mood, Americans slowed their spending in February as prices for food, gasoline, toothpaste and...
Ethisphere Institute lists Hasbro among most ethical companies in world
PAWTUCKET – Hasbro Inc. has been named one of the 2022 World’s Most Ethical Companies by Ethisphere Institute. The Pawtucket-headquartered toy company has made...
R.I. unemployment dips to 4.2% in Jan.; 1,300 jobs lost
CRANSTON – Rhode Island’s uneven economic recovery continued in January, with the monthly unemployment rate dipping three-tenths of a percentage point to 4.2%, according...
Toray completes sale of Old Baptist Road plant
NORTH KINGSTOWN – Toray Plastics (America) Inc. has finalized the sale of its Old Baptist Road facility to a Lowell, Mass.-based manufacturer's Rhode Island...
Dwight named board vice chair of Manufacturing Leadership Council
PAWTUCKET – Daniel Dwight, CEO and president of Cooley Group, a Pawtucket maker of membranes for containment of chemicals and other markets, was elected...
Polaris MEP webinar walks makers through global exporting opportunities
PROVIDENCE – Polaris MEP will host Export Ready, a free webinar featuring the benefits of exporting and exploring what it means to be an...
Applications sought for EforAll South Coast program, promoting veterans’ products
NEW BEDFORD – Entrepreneurship for All South Coast welcomes applications for its veteran product maker vendor list beginning March 12.
The nonprofit organization will be...
Cars lost on massive cargo ship could impact local automobile dealers
NORTH KINGSTOWN — The nearly 1,600 cars bound for the Port of Davisville that sank with the Felicity Ace cargo ship likely won't phase...
Employers still harboring concerns over marijuana legislation
PROVIDENCE – Rhode Island employers say lawmakers have heard their pleas by adding greater employer protections in legislation to legalize marijuana in the state,...
Rubius Therapeutics reports $196.5M loss in 2021
PROVIDENCE – Rubius Therapeutics Inc. on Friday reported a loss of $196.5 million in 2021, or $2.23 per diluted share.
The clinical-stage biopharmaceutical company, which...
- Featured Event -
